Acceleron Reports Third Quarter 2019 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Acceleron Reports Third Quarter 2019 Operating and Financial Results

Acceleron Pharma (XLRN) Misses Q3 EPS by 4c

November 6, 2019 7:54 AM EST

Acceleron Pharma (NASDAQ: XLRN) reported Q3 EPS of ($0.86), $0.04 worse than the analyst estimate of ($0.82). Revenue for the quarter came in at $4.21 million versus the consensus estimate of $4.44 million.

With the FDAs decision on the luspatercept regulatory submission for the treatment of beta-thalassemia expected in less than one month, we are close to achieving a major... More